Established CRO and regulatory leader brings nearly 30 years of expertise, 400+ clinical trials, and flexible decentralized study designs to supplement and ingredient brands.
LAS VEGAS, Oct. 28, 2026 – KGK Science, a contract research organization serving the dietary supplement, nutraceutical, functional food and Natural Product industries, today announced decentralized clinical trial solutions for sponsors in the United States, powered by the Alethios software platform. Introduced at SupplySide Global, the collaboration pairs KGK’s established clinical and regulatory teams with digital tools that help brands conduct rigorous studies with participants across the United States.
Decentralized studies can reach participants across the country, enroll faster and capture data from participants’ daily lives. KGK brings to them the same standards it applies to every study: protocol development, regulatory affairs, clinical operations, data management, statistical analysis and scientific reporting. Sponsors get one partner accountable for the study from design to final report.
This partnership with Alethios for the dietary supplement, nutraceutical, and functional food/beverage industries combines the strengths of both organizations:
- KGK Science brings a traditional commitment through a collaborative protocol design and development phase, ethics and IRB submissions, patient safety oversight, clinical operations, data management, rigorous statistical analysis plans, scientific reporting, and regulatory claim substantiation expertise.
- Alethios provides the operational platform. Study Planner lets KGK’s scientists’ prototype and compare multiple study designs before committing to a protocol, from arms and randomization to endpoints and sample size. Study Operator then runs the study end-to-end: electronic informed consent, remote recruitment through the Alethiad participant community, participant questionnaires, adverse event tracking, and data capture from photos, wearables and at-home biomarker kits, with real-time visibility into enrollment, adherence and data quality.
“Our clients want rigorous science, and they want to reach diverse, real-world participants faster. Decentralized trials let us do both. Study success for sponsors is a win with KGK’s scientific rigor and regulatory expertise applied to every study, while participant access and diversity is increased as we take the clinical trial beyond their doorstep and into their living room” said Najla Guthrie, CEO, KGK Science.
KGK selected Alethios as the preferred technology behind the offering. The platform supports participant recruitment, electronic consent, data capture, wearable and device integrations and at-home testing, giving KGK’s teams a single view of each study as it runs.
“Alethios builds software that gives researchers the tools to design and run rigorous decentralized studies. In the hands of KGK Science, that research infrastructure becomes full-stack support for sponsors who want a single partner from protocol to final report. Sponsors get the best of both worlds: the reach and real-world data of a decentralized study, and the scientific and regulatory depth of an established CRO with decades of experience in this industry,” said Zeenia Framroze, Founder and CEO of Alethios.
What KGK’s decentralized trials offer sponsors
- Full service, from protocol to report. KGK manages study design, regulatory strategy, operations, statistics and reporting leveraging Alethios’ research infrastructure.
- Reach across the United States. Participants can join from home, without travelling to a study site.
- Rich, real-world data. Studies can include validated questionnaires, wearable and sensor data, at-home biomarker testing processed by CLIA-certified, CAP-accredited laboratories, and digital biomarkers for skin, cognition and body composition.
- Hybrid designs. KGK will offer study designs that pair its in-clinic capabilities, such as pharmacokinetic studies, with decentralized studies.
SupplySide Global attendees can learn more at KGK Science booth #4341.
About KGK Science
Founded in 1997 and headquartered in London, Ontario, KGK Science Inc. is a full-service contract research organization specializing in the nutraceutical and natural health products industry. KGK designs and conducts human clinical trials, provides regulatory and claim substantiation expertise, and supports preclinical development, giving consumer health brands the evidence they need to differentiate their products and reach global markets with confidence. For more information, visit kgkscience.com.
About Alethios
Alethios is a software platform delivering research infrastructure for human health. Its AI-powered, full-stack software delivers the capabilities of a study team without the overhead. The platform unifies protocol design, IRB coordination, recruitment, participant management, multimodal data collection, and reporting for decentralized clinical trials. Principal investigators, sponsors, and CROs rely on Alethios to generate rigorous real-world evidence across human health industries. Alethios is a 2026 Nutra Healthspan Innovator Award winner, a 2026 Vitafoods Europe Startup Challenge finalist, and a 2025 NutraIngredients-USA Startup Award finalist. Get started at Alethios.com
Media contacts
KGK Science:
Anusri Nair
Sales & Marketing Manager, KGK Science Inc.
anair@kgkscience.com | 226-272-0801
Alethios: press@alethios.com
